Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice

SUMMARY A subset of patients with Parkinson's disease acquires a debilitating dementia characterized by severe cognitive impairments (i.e. Parkinson's disease dementia; PDD). Brains from PDD patients show extensive cholinergic loss as well as dopamine (DA) depletion. We used a mutant mouse...

Full description

Saved in:
Bibliographic Details
Main Authors: Lilia Zurkovsky (Author), Evgeny Bychkov (Author), Elviche L. Tsakem (Author), Carley Siedlecki (Author), Randy D. Blakely (Author), Eugenia V. Gurevich (Author)
Format: Book
Published: The Company of Biologists, 2013-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9719fbc11bbc4b6e915376b9e94e04cc
042 |a dc 
100 1 0 |a Lilia Zurkovsky  |e author 
700 1 0 |a Evgeny Bychkov  |e author 
700 1 0 |a Elviche L. Tsakem  |e author 
700 1 0 |a Carley Siedlecki  |e author 
700 1 0 |a Randy D. Blakely  |e author 
700 1 0 |a Eugenia V. Gurevich  |e author 
245 0 0 |a Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice 
260 |b The Company of Biologists,   |c 2013-01-01T00:00:00Z. 
500 |a 1754-8403 
500 |a 1754-8411 
500 |a 10.1242/dmm.010363 
520 |a SUMMARY A subset of patients with Parkinson's disease acquires a debilitating dementia characterized by severe cognitive impairments (i.e. Parkinson's disease dementia; PDD). Brains from PDD patients show extensive cholinergic loss as well as dopamine (DA) depletion. We used a mutant mouse model to directly test whether combined cholinergic and DA depletion leads to a cognitive profile resembling PDD. Mice carrying heterozygous deletion of the high-affinity, hemicholinium-3-sensitive choline transporter (CHTHET) show reduced levels of acetylcholine throughout the brain. We achieved bilateral DA depletion in CHTHET and wild-type (WT) littermates via intra-striatal infusion of 6-hydroxydopamine (6-OHDA), or used vehicle as control. Executive function and memory were evaluated using rodent versions of cognitive tasks commonly used with human subjects: the set-shifting task and spatial and novel-object recognition paradigms. Our studies revealed impaired acquisition of attentional set in the set-shifting paradigm in WT-6OHDA and CHTHET-vehicle mice that was exacerbated in the CHTHET-6OHDA mice. The object recognition test following a 24-hour delay was also impaired in CHTHET-6OHDA mice compared with all other groups. Treatment with acetylcholinesterase (AChE) inhibitors physostigmine (0.05 or 0.1 mg/kg) and donepezil (0.1 and 0.3 mg/kg) reversed the impaired object recognition of the CHTHET-6OHDA mice. Our data demonstrate an exacerbated cognitive phenotype with dual ACh and DA depletion as compared with either insult alone, with traits analogous to those observed in PDD patients. The results suggest that combined loss of DA and ACh could be sufficient for pathogenesis of specific cognitive deficits in PDD. 
546 |a EN 
690 |a Medicine 
690 |a R 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Disease Models & Mechanisms, Vol 6, Iss 1, Pp 171-183 (2013) 
787 0 |n http://dmm.biologists.org/content/6/1/171 
787 0 |n https://doaj.org/toc/1754-8403 
787 0 |n https://doaj.org/toc/1754-8411 
856 4 1 |u https://doaj.org/article/9719fbc11bbc4b6e915376b9e94e04cc  |z Connect to this object online.